MEET TERESA
Teresa Simon, MPH, manages PRC+, a multi-specialty clinical trial research center and consulting group specializing in Phase III and IV studies and real-world data collection and epidemiologic assessments. She has more than 25 years of experience in clinical practice, health outcomes, and epidemiology across many areas including but not limited to: infectious diseases, cardiovascular diseases, rheumatic diseases, dermatology, gastroenterology, immunology, GVHD, HIV, hepatitis B and C, and most recently cannabis and psychedelics.
Ms. Simon’s career has included pre- and post-marketing epidemiologic strategic guidance to academics, pharma, and regulatory bodies. She has designed real-world studies to evaluate health outcomes, patient experience, safety-related outcomes, and economic evaluations. Ms. Simon works with academic centers worldwide to implement studies that use observational and patient experience data to detect, quantify, and characterize safety signals that are used to inform the benefits and risks of medicines.
Highlighting her skills in clinical research, Ms. Simon’s strategic and methodologic input and innovation in real-world evidence generation has resulted in regulatory approval in the United States and European Union for products for cardiovascular and immunological conditions. She is skilled at designing and implementing global and local regulatory driven post-marketing commitments. She’s had various leadership roles involving the review and interpretation of data from robust pre- and post-marketing epidemiology studies, which included summarizing report results to health authorities. Ms. Simon excels in ensuring communication of safety data to broader teams and the relevant external communities. She has a proven track record of successfully overseeing all epidemiology budget-related items for all marketing products (E.g., studies N=20-25 yearly; Budget $25-35 million).
Simon holds a graduate-level medical cannabis certificate from Jefferson University, and she is currently collaborating with the PRC+ physician research network to advance science, including education on cannabis and psychedelic treatments.
Simon is a connector with a passion for providing clear and concise information to patients, healthcare providers, and our youth.
MEET LEN
Dr. Leonard Kamen is a board-certified specialist in Physical Medicine and Rehabilitation (PMR) with additional certification in Pain Medicine. For over 30 years, he has served as Medical Director of MossRehab Outpatient Center in northeast Philadelphia. Currently, Kamen is a clinical associate professor of PMR at Thomas Jefferson Hospital/Sidney Kimmel Medical College, including active teaching responsibilities at MossRehab, Einstein Medical Center, Jefferson, and the University of Pennsylvania. He has dedicated his medical profession to serving those with congenital or acquired physical impairments, consequences of trauma, and chronic pain. As a non–interventional pain practitioner, Kamen has focused on a bio-psycho-social approach to pain rehabilitation. This approach involves utilizing multiple medical and non-medical resources to help people with pain achieve a less dependent, self-empowered quality of life.
MEET JAHAN
Jahan Marcu, Ph.D., is one of the top researchers and industry experts in the field of cannabis, contributing to many innovative discoveries, applications, and standards for medical cannabis and its laboratory analysis, cultivation, manufacturing, and dispensing. Dr. Marcu has also created training for the industry and internationally accepted methods for cannabis analysis and has founded institutions and organizations for research, education, and training programs.
He became well-known for demonstrating synergistic interactions for cannabinoids such as THC and CBD in cancer, which has led to the development and marketing of products with those ratios and launched numerous applications and research projects. He helped create the first product standards for cannabis and hemp products, as a chairman of the American Herbal Products Association (AHPA) cannabis committee. Those standards are now being reviewed by ASTM, where he was accepted as a chairman of D37.07 for the committee on cannabis standards for training, certification, and accreditation. Dr. Marcu’s additional work includes helping to solve the structure of cannabinoid receptors, characterizing a class of drugs for cannabinoid receptors called allosteric modulators (CBD being the most popular), and publishing the first product safety study on CBD products.
He is also an author of the American Herbal Pharmacopoeia Cannabis monograph, which helps set standards for cannabis and hemp products for human consumption. His test methods have received national media attention and have been interviewed by Science and Nature for his contributions to basic research and applied innovations. His studies have been covered by numerous cannabis industry journals and national media outlets. His work has received praise and used by regulators, policymakers, and scientists, to address an urgent national need. His research and standards documents are often cited in regulations and used to develop medical cannabis programs.
MEET JOHN
John Simon was the COO of Apex Gaming PCs before returning to his passion in healthcare. Simon served as a clinical research coordinator with PRC+ since 2014 and conducted health economics and outcomes research with Jazz Pharmaceuticals. Currently, he is the director of clinical safety strategy and solutions within the cardiovascular therapeutic area at Bristol Myers Squibb. After graduating with a bachelor of science degree in Public Health from Dornsife School of Public Health, Drexel University, he continues to pursue a master of public health degree in epidemiology.
MEET MATT
Matthew Wabwire graduated with a degree in Public Health from the Dornsife School of Public Health, Drexel University. In the public health sphere, he has worked as a scholar before with the international organization, World Vision, conducting behavioral change research in water, sanitation and hygiene. This work conducted in both the USA and multiple countries in Southern Africa included the development of knowledge assessments, training and implementation of programs, and monitoring and evaluation of programs over their 10-year implementation period. In addition to experience with behavioral change, education, monitoring, and evaluation, he has also conducted research on the burden of cardiovascular diseases in high, middle, and low-income countries.
He has other experience in business development, digital marketing, growth & strategy from working with startups and development organizations in Sub-saharan Africa and the United States with roles as Executive Board Chairman at Nkunzi Foundation - Model Peace Forum, and Business Growth Lead at Apex Gaming PCs.